Inspra (IN-sprah, eplerenone) is now approved for mild to moderate hypertension...not just heart failure

Inspra (IN-sprah, eplerenone) is now approved for mild to moderate hypertension...not just heart failure.

Think of it as an alternative to spironolactone.

These aldosterone antagonists are usually added if other BP meds aren't enough to control blood pressure...or aren't appropriate.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote